Researchers in Hong Kong have found that patients experiencing milder illness caused by the novel coronavirus recover more quickly if they are treated with a three-drug antiviral cocktail soon after symptoms appear.
Authors of the study, published in The Lancet on Friday, described the findings as “early, but important.”
They called for larger-scale research on critically ill patients to ascertain if the drug combo could be a viable treatment for them, too.
“Our trial demonstrates that early treatment of mild to moderate COVID-19 with a triple combination of antiviral drugs may rapidly suppress the amount of virus in a patient’s body,” said University of Hong Kong professor of microbiology Yuen Kwok-yung (袁國勇), who led the research.
The treatment, which appeared safe in patients, was shown to “relieve symptoms, and reduce the risk to healthcare workers by reducing the duration and quantity of viral shedding (when the virus is detectable and potentially transmissible),” Yuen wrote.
Scientists are racing to identify medicines to use against COVID-19, but there is currently no treatment, cure or vaccine.
The study tracked the virus in 127 adults admitted to six hospitals in Hong Kong after they tested positive.
Of those participating, 86 were given a two-week course of three medicines: interferon beta-1b, a drug used to treat multiple sclerosis; a combination of lopinavir and ritonavir used to fight HIV; and ribavirin, used to treat hepatitis.
A randomly assigned control group of 41 people was just given the lopinavir-ritonavir combination.
Treatment began on average five days after symptoms started and all patients otherwise received standard care, including oxygen therapy.
Researchers then measured how long it took for a swab test for the virus to turn out negative. They found that those taking all three medicines were able to clear the coronavirus in seven days on average (between five and 11 days) — “significantly” shorter than the 12-day average for the control group.
Those on the three-drug regimen also saw a complete alleviation of their symptoms in an average of four days, compared with eight for the control group.
“Future clinical study of a double antiviral therapy with interferon beta-1b as a backbone is warranted,” the study said.
UNITED: The premier said Trump’s tariff comments provided a great opportunity for the private and public sectors to come together to maintain the nation’s chip advantage The government is considering ways to assist the nation’s semiconductor industry or hosting collaborative projects with the private sector after US President Donald Trump threatened to impose a 100 percent tariff on chips exported to the US, Premier Cho Jung-tai (卓榮泰) said yesterday. Trump on Monday told Republican members of the US Congress about plans to impose sweeping tariffs on semiconductors, steel, aluminum, copper and pharmaceuticals “in the very near future.” “It’s time for the United States to return to the system that made us richer and more powerful than ever before,” Trump said at the Republican Issues Conference in Miami, Florida. “They
Taiwanese actress Barbie Hsu (徐熙媛) has died of pneumonia at the age of 48 while on a trip to Japan, where she contracted influenza during the Lunar New Year holiday, her sister confirmed today through an agent. "Our whole family came to Japan for a trip, and my dearest and most kindhearted sister Barbie Hsu died of influenza-induced pneumonia and unfortunately left us," Hsu's sister and talk show hostess Dee Hsu (徐熙娣) said. "I was grateful to be her sister in this life and that we got to care for and spend time with each other. I will always be grateful to
GOLDEN OPPORTUNITY: Taiwan must capitalize on the shock waves DeepSeek has sent through US markets to show it is a tech partner of Washington, a researcher said China’s reported breakthrough in artificial intelligence (AI) would prompt the US to seek a stronger alliance with Taiwan and Japan to secure its technological superiority, a Taiwanese researcher said yesterday. The launch of low-cost AI model DeepSeek (深度求索) on Monday sent US tech stocks tumbling, with chipmaker Nvidia Corp losing 16 percent of its value and the NASDAQ falling 612.46 points, or 3.07 percent, to close at 19,341.84 points. On the same day, the Philadelphia Stock Exchange Semiconductor Sector index dropped 488.7 points, or 9.15 percent, to close at 4,853.24 points. The launch of the Chinese chatbot proves that a competitor can
TAIWAN DEFENSE: The initiative would involve integrating various systems in a fast-paced manner through the use of common software to obstruct a Chinese invasion The first tranche of the US Navy’s “Replicator” initiative aimed at obstructing a Chinese invasion of Taiwan would be ready by August, a US Naval Institute (USNI) News report on Tuesday said. The initiative is part of a larger defense strategy for Taiwan, and would involve launching thousands of uncrewed submarines, surface vessels and aerial vehicles around Taiwan to buy the nation and its partners time to assemble a response. The plan was first made public by the Washington Post in June last year, when it cited comments by US Indo-Pacific Commander Admiral Samuel Paparo on the sidelines of the Shangri-La Dialogue
RSS